YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Surgical Equipment & Consumables - Diversified Stocks Q2 Recap: Benchmarking CONMED (NYSE:CNMD) Looking back on surgical equipment & consumables - diversified stocks' Q2 earnings, we examine this quarter's best and worst performers, includ…
Healthcare Equipment and Supplies Stocks Q2 Highlights: GE HealthCare (NASDAQ:GEHC) Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today we are looking a…
3 Healthcare Stocks That Fall Short Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their mom…
3 Mid-Cap Stocks with Open Questions Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract sign…
1 of Wall Street's Favorite Stocks with Exciting Potential and 2 We Brush Off Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it's worth remembering…
Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses As the craze of earnings season draws to a close, here's a look back at some of the most exciting (and some less so) results from Q2. Today, we are…
Steris Corporation logo is displayed on a smartphone screen_By Rafael Henrique STERIS plc (STE), with a market capitalization of approximately $20.8 billion, is a global healthcare company focused on infection prevention and patient care.…
Wall Street's major market averages finished lower on Friday after traders and investors digested the latest jobs data, which came in stronger than forecasted. The blue-chip Dow ended 0.5% lower, the benchmark S&P 500 slipped 0.3%, and the…
It has been about a month since the last earnings report for Steris (STE). Shares have lost about 2.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is…
STERIS stock has delivered a positive 11.2% total return over the past five years, yet current checks suggest the shares now trade close to a fair level rather than offering an obvious discount. The intrinsic value estimate from a Discount…
Conference appearance puts STERIS (STE) in the spotlight STERIS (STE) is drawing investor attention after confirming it will participate in the Morgan Stanley Healthcare Conference in New York on September 15, 2026, with CEO Dan Carestio s…
STERIS plc Dublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, September 1…
Steris Corporation logo is displayed on a smartphone screen_By Rafael Henrique Mentor, Ohio-based STERIS plc (STE) provides infection prevention products and services in the United States and internationally. The company has a market cap o…
STERIS plc STE is making its largest-ever investment in a single manufacturing site with a $600 million formulated chemistries Center of Excellence in North Carolina. The project is designed to expand capacity, improve efficiency and suppo…
STERIS plc STE is entering fiscal 2027 with steady healthcare demand, improving profitability and an unchanged growth outlook. The stock's valuation is below its own five-year median and its medical-instruments sub-industry, but it is not…
3 Reasons STE is Risky and 1 Stock to Buy Instead Over the past six months, STERIS's shares (currently trading at $232.53) have posted a disappointing 7.4% loss, well below the S&P 500's 12.9% gain. This might have investors contemplating…
Ecolab Inc. ECL shares have gained 12.2% over the past three months, drawing attention to whether improving operating momentum can sustain the advance. Faster growth in High-Tech, Digital and Life Sciences, firmer pricing and a higher 2026…
Q2 Rundown: STERIS (NYSE:STE) Vs Other Surgical Equipment & Consumables - Diversified Stocks The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a look at how surgical eq…
Major healthcare heavyweights, including Pfizer (PFE [https://seekingalpha.com/symbol/PFE]), Merck (MRK [https://seekingalpha.com/symbol/MRK]), and Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]), reported their quarterly earnings th…
STERIS plc STE reported first-quarter fiscal 2027 adjusted earnings of $2.59 per share, up 10.7% year over year. The bottom line beat the Zacks Consensus Estimate by 1.97%, supported by higher volume, pricing, productivity and a favorable…
The U.S. economy has remained resilient so far this year, even though the pace of growth has slowed. Gross domestic product (GDP) expanded 1.5% in the second quarter, slowing from 2.1% in the first quarter and missing expectations. Inflati…
STERIS plc recently announced plans to invest US$600 million in its largest-ever manufacturing project, a 600,000 square-foot formulated chemistries Center of Excellence in North Carolina that will consolidate production and distribution a…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. STERIS (STE) has drawn fresh attention after committing US$600 mill…
Steris (STE) reported $1.49 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 7.3%. EPS of $2.59 for the same period compares to $2.34 a year ago. The reported revenue represents a surprise of -0…
STERIS (NYSE:STE) Posts Q2 CY2026 Sales In Line With Estimates Medical equipment and services company Steris (NYSE:STE) met Wall Street's revenue expectations in Q2 CY2026, with sales up 7.3% year on year to $1.49 billion. Its non-GAAP pro…
Steris (STE) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.54 per share. This compares to earnings of $2.34 per share a year ago. These figures are adjusted for non-recurring items. This qu…
STERIS plc Fiscal 2027 first quarter revenue increased 7%; constant currency organic revenue growth was 6% Fiscal 2027 first quarter as reported diluted EPS increased to $2.04; adjusted EPS per diluted share increased to $2.59 Targeted res…
Fiscal 2027 first quarter revenue increased 7%; constant currency organic revenue growth was 6% Fiscal 2027 first quarter as reported diluted EPS increased to $2.04; adjusted EPS per diluted share increased to $2.59Targeted restructuring p…
STERIS plc • This Formulated Chemistries Center of Excellence will support sterilization and disinfection for the global Healthcare and Pharmaceutical industries • This strategic manufacturing investment is the largest in STERIS's history…
Fortive Corporation FTV raised its 2026 adjusted earnings outlook after second-quarter earnings and revenues exceeded estimates as organic growth accelerated. Price, volume and productivity gains broadened across the portfolio. The questio…
Waters (WAT) came out with quarterly earnings of $3.05 per share, beating the Zacks Consensus Estimate of $3.01 per share. This compares to earnings of $2.95 per share a year ago. These figures are adjusted for non-recurring items. This qu…
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. The Morning Bull - US Market Morning Update Friday, Jul, 31 2026 US stock futures are pointing higher this morning, with E-mini S&P…
STERIS plc DUBLIN, IRELAND, July 30, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that the Company will distribute a quarterly interim dividend of $0.69 per share. This represents a $0.06 incr…
STERIS plc STE is scheduled to release first-quarter fiscal 2027 results on Aug. 6, after market close. In the last reported quarter, the company posted adjusted earnings per share (EPS) of $2.83, which missed the Zacks Consensus Estimate…
Q1 Surgical Equipment & Consumables - Diversified Earnings: Zimmer Biomet (NYSE:ZBH) Earns Top Marks As the Q1 earnings season wraps, let's dig into this quarter's best and worst performers in the surgical equipment & consumables - diversi…
STERIS plc DUBLIN, IRELAND, July 27, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2027 first quarter results at 9:00 a.m. ET on August…